ERS International Congress, Milan 2017

---

Experimental PH

Thematic Poster
Chairs: F. Perros (Le Kremlin Bicetre, France), L. Price (London, United Kingdom), D. Montani (Le Kremlin-Bicêtre, France), H. Bogaard (Amsterdam, Netherlands)

Cigarette smoke- and hypoxia-induced imbalanced vasoactive gene expression in human pulmonary artery smooth muscle cells A. Alqarni (Nottingham, United Kingdom)
Common bile duct and portal vein ligations increased right ventricular pressure in rat: a new experimental model F. Ketabchi (Shiraz, Islamic Republic of Iran)
Proangiogenic and wound healing molecular and histological fingerprint of chronic thromboembolic pulmonary hypertension D. Iloska (Bad Nauheim, Germany)
The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43 M. Htet (Glasgow, United Kingdom)
Investigating redox sensitive sex differences in serotonin-induced proliferation and migration in rat pulmonary artery smooth muscle cells. K. Hood (Glasgow, United Kingdom)
Histone Deacetylase 7 regulates master transcription factors and modulates mitochondrial function E. Gamen (Bad Nauheim, Germany)
A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension C. Udjus (Oslo, Norway)
Nintedanib relaxes human pulmonary arteries more potently than murine C. Martin (Aachen, Germany)
Dasatinib increases endothelial permeability leading to pleural effusion C. Phan (le kremlin bicetre dedex, France)
Administration of mitomycin results in pulmonary hypertension and vascular remodeling in rabbits R. Quarck (Leuven, Belgium)
Inhalation of dry powder INS1009 (DP-INS1009) does not activate the cough reflex in guinea pigs: a comparison with nebulized treprostinil. M. Corboz (Bridgewater, United States of America)
The non-prostanoid IP receptor agonist, APD811 (ralinepag) has potent antiproliferative and vasorelaxant properties in human pulmonary artery L. Clapp (London, United Kingdom)
The selective Rho kinase inhibitor trans-6-((4-aminocyclohexyl)amino)-5-fluoro-2-methoxynicotinamide ameliorates experimental pulmonary hypertension S. Cavalli (Parma, Italy)
Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension A. McNair (Glasgow, United Kingdom)
Vascular sexual dimorphism and pulmonary hypertension in a rat chronic hypoxia model. A. Rocher (Valladolid, Spain)
Specific ligand for the innate repair receptor, ARA290, attenuates pulmonary hypertension in an elastase-induced murine model of emphysema K. Howell (Dublin, Ireland)
Longitudinal cardiac changes in a SUGEN/Hypoxic Rat Model of Pulmonary Hypertension determined by Cardiac MRI G. Jayasekera (GLASGOW, United Kingdom)
Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension V. Smolders (Barcelona, Spain)
Neutralization of CXCL12 reverses established pulmonary hypertension in the sugen-hypoxia rat model J. Bordenave (Le Kremlin-Bicêtre Cedex, France)